Anticancer vaccines gain new lease of life with personalisation techniques

Anticancer vaccines have gained a new lease of life with techniques to personalise them to individual patients. Cutting edge developments in this re-energised field were revealed at the ESMO Immuno-Oncology Congress in Geneva, Switzerland. The original anticancer vaccines, launched in the late 1990s, were based on shared tumour antigens and failed to induce a potent immune response.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Development Research and Development Source Type: news